These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Experience of the use of nebivolol in the treatment of hypertension in postmenopausal women].
    Author: Bart BIa, Benevskaia VF, Buval'tsev VI, Boronenkov GM.
    Journal: Kardiologiia; 2002; 42(8):20-4. PubMed ID: 12494089.
    Abstract:
    Nebivolol was given to 30 hypertensive postmenopausal women as monotherapy (5-10 mg/day) or in combination with hydrochlorothiazide. Clinical effect was achieved in 76.6 and 86.7% of women on mono- and combination therapy, respectively. Hypotensive effect was confirmed by 24-hour blood pressure monitoring. Blood pressure lowering was associated with decrease of total peripheral resistance and regression of left ventricular hypertrophy. Nebivolol appeared to be metabolically neutral and only sporadic adverse effects were registered.
    [Abstract] [Full Text] [Related] [New Search]